Cargando…
Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs
Platinum(II) complexes such as cisplatin, carboplatin and oxaliplatin are clinically approved for the therapy of various solid tumors. Challenging pathogenic properties of cancer cells and the response of cancers towards platinum-based drugs are strongly influenced by non-coding small RNA molecules,...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
KeAi Publishing
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096430/ https://www.ncbi.nlm.nih.gov/pubmed/30159416 http://dx.doi.org/10.1016/j.ncrna.2016.10.001 |